Cerner's (CERN) Reports In-Line EPS Due to Better Than Expected GM and Tax; Cowen Cuts Price Target to $70

Cerner (CERN) PT Cut to $75 at UBS on Mixed Outlook

UBS analyst Steven Valiquette reiterated a Buy rating but lowered his price target on Cerner (NASDAQ: CERN) to $75.00 (from $80.00) following Q3 results which also included a mixed outlook.

commented, "While the local Royals just won the World Series, Kansas City... More

Cerner (CERN) Numbers Cut at Piper Jaffray But Remains Positive on 'High Quality Bookings Beat'

Piper Jaffray analyst Sean Wieland cut estimates and his price target on Cerner (NASDAQ: CERN) to $82.00 (from $87.00) but maintained an Overweight rating. While revenue was weak, high quality bookings keeps them positive.

Wieland commented, "The dog ate their homework again on revenue, but... More

Leerink Partners Maintains Bullish View on Cerner (CERN) Despite Revenue Weakness and Disappointing Guidance

Leerink Partners analyst David Larsen maintained an Outperform rating and $80 price target on Cerner (NASDAQ: CERN) following Q3 results which showed record bookings but revenue weakness and disappointing guidance.

Larsen commented, "This afternoon CERN reported 3Q:15 results with total revenue of $1,128M... More

After-Hours Movers 11/03: (TSLA) (ZEN) (CBS) Higher; (ENPH) (QUAD) (X) Lower (more...)

Enphase Energy (NASDAQ: ENPH) 21.8% LOWER; reported Q3 EPS of $0.08, $0.05 better than the analyst estimate of $0.03. Revenue for the quarter came in at $102.9 million versus the consensus estimate of $102.95 million. Enphase Energy sees Q4 2015 revenue of $62-70 million, versus the consensus of $111.67 million.

Quad/Graphics (NYSE: QUAD) 14% LOWER; reported Q3 EPS of $0.14, $0.27 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.21 billion.

DSW, Inc. (NYSE:... More

Cerner (CERN) Reports In-Line Q3 EPS, Offers Q4 and FY16 Guidance

Cerner (NASDAQ: CERN) reported Q3 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.17 billion.

Cerner sees Q4 2015 EPS of $0.56-$0.58, versus the consensus of $0.61. Cerner sees Q4 2015 revenue of $1.15-1.20 billion, versus the... More

Trading Radar for 11/3: Groupon (GRPN), Mosaic (MOS), Kellogg (K), Herbalife (HLF), Zillow (Z) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

1-800-FLOWERS.com (Nasdaq: FLWS) - consensus loss $0.26
ALLETE, Inc. (NYSE: ALE) - consensus EPS $1.00
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.21
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.63
ARIAD Pharma0 (Nasdaq: ARIA) - consensus loss $0.23
Aircastle Limited (NYSE: AYR) - consensus EPS... More

Streetinsider.com's Hot Lunchtime Reads 11/2: (MDAS) (CERN) (FB) (MSFT) (ODP)

The following is a list of notable articles to help get you through the lunch hour:Valuation in MedAssets (MDAS) Deal 'Seems Fair'; Competing Offer Unlikely - FBR ->... More

Cerner (CERN) Could Miss and Guide Down Tues - Stifel

Steven Rubis from Stifel reduced revenue estimates on Cerner (NASDAQ: CERN) ahead of earnings scheduled for Tuesday after the close. He is concerned about the slowing organic growth and believes it could cause investors to become more cautious on the name going forward.

Based on CPSIs 3Q15 results, it is possible that there... More